The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
PaxMedica, Inc.(NASDAQ:PXMD)


PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indi...
Website: https://www.paxmedica.com
Founded: 2018
IPO Price: $5.25 (Aug 26, 2022)
Full Time Employees: 2
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
PaxMedica . Op Cashflow Per Share ttm
PaxMedica . Free Cashflow Per Share ttm
PaxMedica . Cash Per Share ttm
PaxMedica . (GAAP) P/E ratio ttm
PaxMedica . P/B ratio ttm
No extra charts and metrics for this ticker.